Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program.

Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program. Abstract Text:

J L Temple,B H Wrotniak,R A Paluch,J N Roemmich,L H Epstein,

OBJECTIVE: To determine if the sex of the participating parent/child pair is a contributing factor in initial weight loss and maintenance within a family-based obesity treatment program. DESIGN: A 2-year family-based obesity treatment program targeting one overweight parent and one overweight child. SUBJECTS: One overweight parent (body mass index (BMI) > or = 25) and child (> or = 85th BMI percentile) from 164 families. MEASUREMENTS: Parameters of body weight, including height, weight, BMI, z-BMI, percent overweight (BOV) at baseline and at 6-, 12- and 24-month follow-up time points. RESULTS: Children within the opposite-sex dyads had greater weight loss (P < 0.01) at 6- and 12-month time points compared with children in the same-sex dyads. Parents within opposite-sex dyads had significantly greater weight loss at 24 months (P < 0.05) compared with those in the same-sex dyads. When individual dyads were examined, the change in child z-BMI after 6 months was greater for the mother-son dyad as compared to the mother-daughter and father-son (P < 0.05). For parent z-BMI, the mother-daughter dyad consistently exhibited the poorest results. At 6- and 12-month time points, parents in the mother-daughter dyad lost significantly less weight than parents in all other dyads (P < 0.05), and at 24 months, parents in the mother-daughter dyad lost less weight than parents in the opposite-sex dyads (P < 0.05). CONCLUSION: These data reveal that child-parent sex interactions can strongly influence the outcome of obesity treatment when both parent and child are the target for weight loss. The reasons that underlie this effect remain to be determined.

Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program. Publishing Authors By Initials

JL Temple,BH Wrotniak,RA Paluch,JN Roemmich,LH Epstein,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: International journal of obesity (2005)

VOLUME: 30

Page Numbers: 1260-4

Journal Abbreviation:

ISSN: 0307-0565

DAY: 21

MONTH: 02

YEAR: 2006

Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101256108

Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program.

AFFILIATION: Division of Behavioral Medicine, Department of Pediatrics, University at Buffalo, Buffalo, NY 14214, USA. jltemple@buffalo.edu

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Obes (Lond)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program Related Publications

• A pharmacy benefit manager perspective.
• Analgesic and Antiinflammatory Activity of Antibodies to Histamine under Experimental Conditions.
• Antibodies to delta sleep-inducing Peptide in ultralow doses: study of the effect by enzyme immunoassay.
• Antiulcer Activity of Ultralow Doses of Antibodies to Histamine under Experimental Conditions.
• Changes in Immunological Parameters in Patients with Opium Abuse Receiving ANAR Therapy.
• Clinical efficiency of epigam in patients with exacerbation of peptic ulcer disease of the stomach and duodenum.
• Co-twin control designs for testing behavioral economic theories of child nutrition: methodological note.
• Coexistence, competition and hypercyclic interaction in some systems of biological interest.
• Effect of Potentiated Antibodies to Cyclophosphamide on the Development of Tumors and Effectiveness of Cytostatic Therapy under Experimental Conditions.
• Effect of Potentiated Solutions on Mercury(II) Signal in Inversion Voltammetry.
• Effect of Preparations from Potentiated Ethanol on the Content of Biogenic Monoamines and Metabolism of Ethanol in Tissues of Rats during Alcoholization.
• Effect of allotransplantation of embryonic brain tissues and administration of potentiated antibodies to bombesin on hemodynamics in rats with emotional hypertension.
• Effect of antibodies to morphine in ultralow doses on induction of long-term potentiation in hippocampal slices from rats with chronic morphine dependence.
• Effect of potentiated antibodies to morphine on behavioral reactions in rats with morphine dependence.
• Effects of Potentiated Antibodies Against Brain-Specific S100 Protein on Biogenic Amine Content and Lipid Peroxidation in Rats under Conditions of Alcoholization.
• Effects of ultralow doses of antibodies to prostate-specific antigen on morphological and functional state of rat prostate.
• Efficiency of ultralow doses of antibodies to s100 protein and delta sleep-inducing Peptide in rats with anxious depression.
• Impaza and sildenafil: comparison of clinical effectiveness in patients with erectile dysfunction.
• Membranotropic effects of antibodies to s100 protein in ultralow doses.
• Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells.
• Potentiated Antibodies to Tumor Necrosis Factor-alpha in the Therapy of Patients with Rheumatoid Arthritis.
• Potentiated antibodies against morphine: effects on biogenic amines and lipid peroxidation in chronically morphinized rats.
• Potentiated cyclophosphane: experimental study of the effect on tumor development and efficiency of cytostatic therapy.
• Proproten-100 in the therapy of patients with the alcohol withdrawal syndrome.
• Regulatory activity of ultralow doses.
• Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program.
• Reperfused myocardial infarction in mice: 3D mapping of late gadolinium enhancement and strain.
• The challenge of Down syndrome.
• Ultralow Doses of Anti-Idiotypic Antibodies to Human gamma-Interferon: Immunotropic Properties.
• Use of potentiated preparations to relieve alcohol and opium withdrawal syndromes.